Regulatory News:
Cellectis (Paris:ALCLS) Cellectis, the genome engineering specialist, is announcing the appointment of Philippe Valachs as Company Secretary.
Philippe Valachs, 52, was previously a managing partner in the lobbying firm Archimede Consultants since 2003, and an associate director of the French think-tank Cercle des Economistes between 2004 and 2008.
A trained economist, he began his career in consulting, working internationally, before joining the cabinet of the French Minister for Industry and Foreign Trade (1991-1993). He then moved to Compagnie Générale des Eaux (now Vivendi), where he was appointed the Chairman's Chief of Staff in 1996. In 1999, he embarked on an entrepreneurial project, participating in the creation of Europe's first webTV, Canalweb.
For André Choulika, Chairman and CEO of Cellectis: "Philippe Valachs' appointment as Company Secretary represents an added strength for Cellectis' executive leadership team. It is also in line with the Group's development and structuring".
About Cellectis
Cellectis improves life by applying its genome engineering expertise to a broad range of applications, including human therapeutics, biological research and agriculture. Cellectis is listed on the NYSE-Euronext Paris Alternext market (code: ALCLS).
To find out more, visit www.cellectis.com.
Disclaimer
This press release and the information contained herein do not constitute an offer to sell or subscribe, or a solicitation of an offer to buy or subscribe, for shares in Cellectis in any country. This press release contains forward-looking statements that relate to the Company's objectives based on the current expectations and assumptions of the Company's management only and involve risk and uncertainties that could cause the Company to fail to achieve the objectives expressed by the forward-looking statements above.
Contacts:
Cellectis
Alexis Breton / Cyril Combe, +33 (0)1 53 65 68 68
cellectis@calyptus.net
